International, randomized phase 3 study results: Ibrutinib versus Chlorambucil in patients 65 years and older with treatment-naive CLL (RESONATE-2 (TM))

Burger, J, Tedeschi, A, Barr, PM et al. (32 more authors) (2016) International, randomized phase 3 study results: Ibrutinib versus Chlorambucil in patients 65 years and older with treatment-naive CLL (RESONATE-2 (TM)). In: Oncology Research and Treatment. Annual conference of the German, Austrian and Swiss Societies for Haematology and Medical Oncology, 14-18 Oct 2016, Leipzig, Germany. Karger Publishers , p. 6.

Metadata

Authors/Creators:
  • Burger, J
  • Tedeschi, A
  • Barr, PM
  • Robak, T
  • Owen, C
  • Ghia, P
  • Bairey, O
  • Hillmen, P
  • Bartlett, NL
  • Li, J
  • Simpson, D
  • Grosicki, S
  • Devereux, S
  • Mccarthy, H
  • Coutre, S
  • Quach, H
  • Gaidano, G
  • Maslyak, Z
  • Stevens, DA
  • Janssens, A
  • Offner, F
  • Mayer, J
  • O'Dwyer, M
  • Hellmann, A
  • Schuh, A
  • Siddiqi, T
  • Polliack, A
  • Tam, CS
  • Suri, D
  • Cheng, M
  • Clow, F
  • Styles, L
  • James, DF
  • Kipps, TJ
  • Investigators, R
Dates:
  • Published: October 2016
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > Institute of Molecular Medicine (LIMM) (Leeds) > Section of Experimental Haematology (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 30 Jun 2017 15:24
Last Modified: 30 Jun 2017 15:24
Status: Published
Publisher: Karger Publishers
Identification Number: https://doi.org/10.1159/000449050
Related URLs:

Download

Share / Export

Statistics